Your browser doesn't support javascript.
loading
Correction for: ASXL1 promotes adrenocortical carcinoma and is associated with chemoresistance to EDP regimen.
Wang, Liang; Lyu, Yinfeng; Li, Yuqing; Li, Kunping; Wen, Hui; Feng, Chenchen; Li, Ning.
Affiliation
  • Wang L; Department of Urology, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China.
  • Lyu Y; Department of Urology, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China.
  • Li Y; Department of Urology, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China.
  • Li K; Department of Urology, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China.
  • Wen H; Department of Urology, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China.
  • Feng C; Department of Urology, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China.
  • Li N; Department of Urology, Fourth Affiliated Hospital of China Medical University, Shenyang 100032, Liaoning Province, P.R. China.
Aging (Albany NY) ; 15(20): 11690-11691, 2023 10 30.
Article in En | MEDLINE | ID: mdl-37906268

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Aging (Albany NY) Journal subject: GERIATRIA Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Aging (Albany NY) Journal subject: GERIATRIA Year: 2023 Document type: Article